ATMIN and nasopharyngeal carcinoma: In the present study, we identified ATMIN as a chemoresistance gene in response to TPF chemotherapy in NPC patients and confirmed that ATMIN promotes docetaxel-resistance and tumor growth both in vitro and in vivo.